IRIS
FIORINO, GIONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 977
EU - Europa 798
AS - Asia 257
SA - Sud America 2
OC - Oceania 1
Totale 2.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 976
SE - Svezia 314
IE - Irlanda 234
CN - Cina 142
SG - Singapore 114
DE - Germania 63
UA - Ucraina 58
GB - Regno Unito 51
IT - Italia 28
FR - Francia 22
FI - Finlandia 18
BE - Belgio 5
CH - Svizzera 3
BR - Brasile 2
CA - Canada 1
HR - Croazia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 2.035
Salva come PNG Salva come JPEG
Città #
Chandler 280
Dublin 234
Nyköping 133
Jacksonville 128
Singapore 94
Ashburn 90
Beijing 66
Dearborn 45
Lancaster 39
Princeton 38
Medford 36
Cambridge 35
Des Moines 31
Boardman 27
Ann Arbor 17
Jinan 13
Shenyang 13
Los Angeles 12
San Mateo 9
Tianjin 8
Helsinki 7
Pozzuolo Martesana 6
Wilmington 6
Zhengzhou 6
Brussels 5
Hebei 5
Washington 5
Bremen 4
Messina 4
Taizhou 4
Woodbridge 4
Fuzhou 3
Guangzhou 3
Lanzhou 3
Nanchang 3
Rome 3
Changsha 2
Haikou 2
Hangzhou 2
Houston 2
London 2
Milan 2
Munich 2
Nanjing 2
Tappahannock 2
Zurich 2
Adliswil 1
Bitonto 1
Brighton 1
Bromsgrove 1
Brooklyn 1
Carini 1
Catania 1
Chicago 1
Hebi 1
Jiaxing 1
Leicester 1
Meda 1
Mountain View 1
Ningbo 1
Norwalk 1
Ottawa 1
Santa Clara 1
Shanghai 1
Stockholm 1
Taiyuan 1
The Dalles 1
Trecastagni 1
Urbana 1
Zagreb 1
Totale 1.463
Salva come PNG Salva come JPEG
Nome #
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 76
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 73
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 69
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 67
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 66
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 65
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 63
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 60
Adalimumab in ulcerative colitis: hypes and hopes 60
Acute Severe Colitis: Infliximab and/or Cyclosporine? 59
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 59
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. 58
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 57
Anti-TNF Therapy in Inflammatory Bowel Diseases 56
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 56
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 55
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. 54
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 54
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. 54
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 54
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. 52
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 52
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. 51
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 49
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 48
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 48
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 44
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 40
Videocapsule Endoscopy in Portal Hypertension 39
Risk of postoperative recurrence and postoperative management of Crohn's disease. 39
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 39
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 38
null 37
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. 36
Mucosal healing in Ulcerative Colitis: Where do we Stand? 36
MRI in Crohn's disease-current and future clinical applications. 36
null 31
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. 31
New drug delivery systems in inflammatory bowel disease: MMX and taylored delivery to the gut. 30
null 27
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease. 27
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 19
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 4
Totale 2.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 0 0 39 31 2 47 52 5
2020/2021292 35 0 74 31 10 34 1 3 1 41 33 29
2021/2022246 1 20 3 12 5 1 8 8 1 36 54 97
2022/2023797 73 71 42 102 50 80 15 34 308 10 8 4
2023/2024189 14 29 7 48 20 30 3 13 2 16 0 7
2024/2025139 5 6 25 49 26 28 0 0 0 0 0 0
Totale 2.068